ATE135585T1 - Anticoagulatorische zusammensetzung aus laci und sulfatierten polysacchariden - Google Patents

Anticoagulatorische zusammensetzung aus laci und sulfatierten polysacchariden

Info

Publication number: ATE135585T1
Authority: AT; Austria
Prior art keywords: laci; anticoagulatory; composition; sulfated polysaccharides; sulfated
Prior art date: 1990-08-27

Application number

AT91870132T

Other languages

English (en)

Inventor

Tze-Chein Wun

Original Assignee

Monsanto Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-08-27

Filing date

1991-08-26

Publication date

1996-04-15

1991-08-26 Application filed by Monsanto Co filed Critical Monsanto Co

1996-04-15 Application granted granted Critical

1996-04-15 Publication of ATE135585T1 publication Critical patent/ATE135585T1/de

Links

230000002429 anti-coagulating effect Effects 0.000 title abstract 2
150000004676 glycans Chemical class 0.000 title abstract 2
229920001282 polysaccharide Polymers 0.000 title abstract 2
239000005017 polysaccharide Substances 0.000 title abstract 2
102100030951 Tissue factor pathway inhibitor Human genes 0.000 title 1
101710139626 Tissue factor pathway inhibitor Proteins 0.000 title 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 1
102000004895 Lipoproteins Human genes 0.000 abstract 1
108090001030 Lipoproteins Proteins 0.000 abstract 1
230000015271 coagulation Effects 0.000 abstract 1
238000005345 coagulation Methods 0.000 abstract 1
-1 heparin Chemical class 0.000 abstract 1
229920000669 heparin Polymers 0.000 abstract 1
229960002897 heparin Drugs 0.000 abstract 1
230000005764 inhibitory process Effects 0.000 abstract 1
230000002195 synergetic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8114—Kunitz type inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Diabetes (AREA)
Hematology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT91870132T 1990-08-27 1991-08-26 Anticoagulatorische zusammensetzung aus laci und sulfatierten polysacchariden ATE135585T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US57308390A	1990-08-27	1990-08-27

Publications (1)

Publication Number	Publication Date
ATE135585T1 true ATE135585T1 (de)	1996-04-15

Family

ID=24290576

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91870132T ATE135585T1 (de)	1990-08-27	1991-08-26	Anticoagulatorische zusammensetzung aus laci und sulfatierten polysacchariden

Country Status (10)

Country	Link
EP (1)	EP0473564B1 (de)
JP (1)	JPH0733336B2 (de)
AT (1)	ATE135585T1 (de)
CA (1)	CA2049873C (de)
DE (1)	DE69118056T2 (de)
DK (1)	DK0473564T3 (de)
ES (1)	ES2085462T3 (de)
GR (1)	GR3020312T3 (de)
IE (1)	IE913004A1 (de)
PT (1)	PT98779B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5610148A (en) *	1991-01-18	1997-03-11	University College London	Macroscopically oriented cell adhesion protein for wound treatment
US5629287A (en) *	1991-01-18	1997-05-13	University College London	Depot formulations
US5276015A (en) *	1992-03-18	1994-01-04	Washington University	Method of inhibiting microvascular thrombosis
US6063764A (en) *	1992-06-01	2000-05-16	Washington University & Chiron Corp.	Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US20030171292A1 (en)	1992-06-01	2003-09-11	Creasey Abla A.	Method for using lipoprotein associated coagulation inhibitor to treat sepsis
ITPD940054A1 (it)	1994-03-23	1995-09-23	Fidia Advanced Biopolymers Srl	Polisaccaridi solfatati
PT769962E (pt) *	1994-07-07	2003-07-31	Univ Washington	Metodo de atenuacao da estenose arterial
EP0774001B1 (de) *	1994-08-05	2002-10-16	Chiron Corporation	Herstellung des inhibitors fuer die komplexbildung des gewebefaktors
US5589359A (en)	1994-08-05	1996-12-31	Chiron Corporation	Chimeric proteins
AU759412B2 (en) *	1995-06-07	2003-04-17	G.D. Searle & Co.	Method of solubilizing, purifying and refolding protein and compositions comprising proteins and solubilizing agents
EP0837883B1 (de) *	1995-06-07	2005-08-10	Chiron Corporation	Methode zur lösung, reinigung und rückfaltung von protein
AU2003200506B2 (en) *	1995-06-07	2007-01-18	G.D. Searle Llc	Method of solubilizing, purifying and refolding protein and compositions comprising proteins and solubilizing agents
US5772629A (en) *	1995-10-23	1998-06-30	Localmed, Inc.	Localized intravascular delivery of TFPI for inhibition of restenosis in recanalized blood vessels
AU1042597A (en) *	1995-12-18	1997-07-14	Stichting Sanquin Bloedvoorziening	Potentiation of complement and coagulation inhibitory properties of c1-inhibitor.
IL161407A0 (en)	2001-10-15	2004-09-27	Chiron Corp	Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi)
US7851433B2 (en)	2003-08-13	2010-12-14	Novartis Vaccines And Diagnostics, Inc.	Method of purifying TFPI and TFPI analogs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL87172A (en) *	1987-07-23	1994-12-29	Univ Washington	Method of isolating highly purified tissue factor inhibitor
IL87171A (en) *	1987-11-23	1995-08-31	Monsanto Co	cDNA of human tissue factor inhibitor
EP0439442B1 (de) *	1990-01-25	1996-03-06	Washington University	Faktor X-LACI-Hybridprotein

1991
- 1991-08-26 CA CA002049873A patent/CA2049873C/en not_active Expired - Lifetime
- 1991-08-26 AT AT91870132T patent/ATE135585T1/de not_active IP Right Cessation
- 1991-08-26 PT PT98779A patent/PT98779B/pt not_active IP Right Cessation
- 1991-08-26 JP JP3213844A patent/JPH0733336B2/ja not_active Expired - Fee Related
- 1991-08-26 ES ES91870132T patent/ES2085462T3/es not_active Expired - Lifetime
- 1991-08-26 IE IE300491A patent/IE913004A1/en not_active IP Right Cessation
- 1991-08-26 DK DK91870132.7T patent/DK0473564T3/da active
- 1991-08-26 EP EP91870132A patent/EP0473564B1/de not_active Expired - Lifetime
- 1991-08-26 DE DE69118056T patent/DE69118056T2/de not_active Expired - Lifetime
1996
- 1996-06-20 GR GR960401682T patent/GR3020312T3/el unknown

Also Published As

Publication number	Publication date
DK0473564T3 (da)	1996-04-15
EP0473564B1 (de)	1996-03-20
DE69118056D1 (de)	1996-04-25
GR3020312T3 (en)	1996-09-30
PT98779B (pt)	1999-06-30
IE913004A1 (en)	1992-03-11
PT98779A (pt)	1992-07-31
JPH04257524A (ja)	1992-09-11
CA2049873C (en)	2001-12-04
EP0473564A1 (de)	1992-03-04
ES2085462T3 (es)	1996-06-01
JPH0733336B2 (ja)	1995-04-12
DE69118056T2 (de)	1996-10-24
CA2049873A1 (en)	1992-02-28

Similar Documents

Publication	Publication Date	Title
DE69118056D1 (de)	1996-04-25	Anticoagulatorische Zusammensetzung aus LACI und sulfatierten Polysacchariden
AU5841090A (en)	1991-01-08	Sulphated polysaccharides, anticoagulant agent and anticomplementary agent obtained from brown algae fucuses and method of obtaining same
MD950086A (ro)	1997-01-31	Utilizare a analogilor nucleozidici ai 1,3-oxatiolanei in tratamentul hepatitei B Use of 1,3-oxathiolan nucleoside analogues in the treatment of hepatitis B
DK0788546T3 (da)	2007-04-10	Nematode-ekstraherede serinproteaseinhibitorer og antikoagulerende proteiner
ES2059296T1 (es)	1994-11-16	Inhibidores de proteasa retroviral.
IT1316986B1 (it)	2003-05-26	Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.
AU2406402A (en)	2002-06-03	Substituted benzene derivatives or salts thereof
NO953372D0 (no)	1995-08-28	Anvendelse av lamotrigin ved behandling av neuro-AIDS
NO942551D0 (no)	1994-07-06	Humanproteaseinhibitorvariant av Kunitz-type
ATE10340T1 (de)	1984-12-15	Stabilisierung der aktivitaet des faktors viii im blutplasma.
ES2136091T3 (es)	1999-11-16	Inhibidores de catepsina g y elastasa para prevenir la degradacion del tejido conectivo.
DK0380331T3 (da)	1994-02-14	Anvendelse af di-tert.butylhydroxyphenylthioderivater til fremstilling af et lægemiddel til behandling eller forebyggelse af arteriosklerose eller atherosklerose
DK0451547T3 (da)	1993-12-29	1,4,8-triazacyclotridecanderivater med prolylendopeptidase inhiberende aktivitet
ATE143810T1 (de)	1996-10-15	Hepatozytwachstumsfaktor enthaltende mittel
ATE108801T1 (de)	1994-08-15	Antikoagulierende peptid-alkohole.
ATE92325T1 (de)	1993-08-15	Kombinationspraeparat mit antithrombotischer wirkung.
FR2662092B1 (fr)	1992-08-28	Ski.
PT666755E (pt)	2003-09-30	Inibicao da infeccao pelo vih
ES2092970T3 (es)	1997-06-01	Procedimiento y maquina de desbarbado.
DK0520372T3 (da)	1997-05-12	Inositol-phosphat-analoger som calciumantagonistiske stoffer
DK0427402T3 (da)	1993-08-16	Anvendelse af cyclodextriner og derivater deraf
ES2056997T3 (es)	1994-10-16	Copolimeros de estireno estabilizados, que contienen particulas de elastomeros.
DE69003342D1 (de)	1993-10-21	Pharmazeutische Zusammensetzungen.
DK332786A (da)	1986-07-11	Anvendelse af 1,4-dihydropyridinderivater og kombinationer deraf med calcitoniner
RU1777840C (ru)	1992-11-30	Устройство дл создани и/или поддержани ишемической зоны во врем операции на конечности

Legal Events

Date	Code	Title	Description
2011-05-15	REN	Ceased due to non-payment of the annual fee